References
- Gonçalves R, Lourenço A, Da Silva SN. A social cost perspective in the wake of the Portuguese strategy for the fight against drugs. Int J Drug Policy. 2015;26(2):199–209.
- Lievens D, Vander Laenen F, Verhaeghe N, et al. Economic consequences of legal and illegal drugs: the case of social costs in Belgium. Int J Drug Policy. 2017;44:50–57.
- Verhaeghe N, Lievens D, Annemans L, et al. Methodological considerations in social cost studies of addictive substances: a systematic literature review. Front Public Health. 2017;4:295.
- Barrio P, Reynolds J, García-Altés A, et al. Social costs of illegal drugs, alcohol and tobacco in the European Union: a systematic review. Drug Alcohol Rev. 2017;36(5):578–588.
- Anderson P, Baumberg B. Alcohol in Europe. London: Institute of Alcohol Studies. A public health perspective; 2006.
- Collins D, Lapsley H (2008). The avoidable costs of alcohol abuse in Australia and the potential benefits of effective policies to reduce the social costs of alcohol. Department of health and ageing (Australian Government).
- Jarl J, Johansson P, Eriksson A, et al. The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ. 2008;9(4):351–360.
- Drummond MF, Sculpher MJ, and Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford university press; 2015.
- Tarricone R. Cost-of-illness analysis: what room in health economics? Health Policy. 2006;77(1):51–63.
- Hammitt JK. QALYs versus WTP. Risk Anal. 2002;22(5):985–1001.
- Oliver A. Testing the internal consistency of the lottery equivalents method using health outcomes. Health Econ. 2005;14(2):149–159.
- Bleichrodt H, Abellan-Perpiñan JM, Pinto-Prades JL, et al. Resolving inconsistencies in utility measurement under risk: tests of generalizations of expected utility. Manage Sci. 2007;53(3):469–482.
- Abellán Perpiñán JM, Sanchez Martinez FI, Martínez Pérez JE, et al. Lowering the ‘floor’ of the SF‐6D scoring algorithm using a lottery equivalent method. Health Econ. 2012;21(11):1271–1285.
- McCord M, de Neufville R. Lottery equivalents: reduction of the certainty effect problem in utility assessment. Manage Sci. 1986;32(1):56–60.
- Green MC, Brazier J, Deverill M. Valuing health-related quality of life. Pharmacoeconomics. 2000;17(2):151–165.
- Tsuchiya A, Brazier J, Roberts J. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ. 2006;25(2):334–346.
- Nimdet K, Chaiyakunapruk N, Vichansavakul K, et al. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold? PloS One. 2015;10(4):e0122760.
- Ryen L, Svensson M. The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ. 2015;24(10):1289–1301.
- Vallejo-Torres L, García-Lorenzo B, Rivero-Arias O, et al. The societal monetary value of a QALY associated with EQ-5D-3L health gains. Eur J Health Econ. 2020;21(3):363–379.
- Jeanrenaud C, Pellegrini S. Valuing intangible costs of alcohol dependence: a contingent valuation study. Revue d’économie politique. 2007;117(5):813–825.
- Petrie D, Doran C, Shakeshaft A. Willingness to pay to reduce alcohol-related harm in Australian rural communities. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):351–363.
- Mosquera Nogueira J, Rodríguez-Míguez E. Intangible costs of alcohol dependence from the perspective of patients and their relatives: a contingent valuation study. Adicciones. 2018;30(2):111–122.
- Stouthard ME, Essink-Bot ML, Bonsel GJ, DUTCH DISABILITY WEIGHTS (DDW) GROUP. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health. 2000;10(1):24–30.
- Sanderson K, Andrews G, Corry J, et al. Using the effect size to model change in preference values from descriptive health status. Qual Life Res. 2004;13(7):1255–1264.
- Kraemer KL, Roberts MS, Horton NJ, et al. Health utility ratings for a spectrum of alcohol-related health states. Med Care. 2005;43(6):541–550.
- Rodríguez-Míguez E, Mosquera Nogueira J. Measuring the impact of alcohol-related disorders on quality of life through general population preferences. Gac Sanit. 2017;31(2):89–94.
- Saarni SI, Suvisaari J, Sintonen H, et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007;190(4):326–332.
- Petrie D, Doran C, Shakeshaft A, et al. The relationship between alcohol consumption and self-reported health status using the EQ5D: evidence from rural Australia. Soc Sci Med. 2008;67(11):1717–1726.
- Maheswaran H, Petrou S, Rees K, et al. Estimating EQ-5D utility values for major health behavioural risk factors in England. J Epidemiol Community Health. 2013;67(2):172–180.
- Mosquera Nogueira J, Rodríguez-Míguez E. Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life. Eur J Health Econ. 2015;16(4):347–356.
- Günther OH, Roick C, Angermeyer MC, et al. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug Alcohol Depend. 2008;92(1–3):291–295.
- Luquiens A, Reynaud M, Falissard B, et al. Quality of life among alcohol-dependent patients: how satisfactory are the available instruments? A systematic review. Drug Alcohol Depend. 2012;125(3):192–202.
- Essex HN, White IR, Khadjesari Z, et al. Quality of life among hazardous and harmful drinkers: EQ-5D over a 1-year follow-up period. Qual Life Res. 2014;23(2):733–743.
- Payakachat N, Ali MM, Tilford JM. Can the EQ-5D detect meaningful change? A systematic review. Pharmacoeconomics. 2015;33(11):1137–1154.
- Chavez LJ, Bradley K, Tefft N, et al. Preference weights for the spectrum of alcohol use in the US population. Drug Alcohol Depend. 2016;161:206–213.
- Casal B, Rodríguez-Míguez E, and Rivera B. Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments. Eur J Health Econ. 2020;21:1039–1048.
- Møller L, Matic S, & World Health Organization. (2010). Best practice in estimating the costs of alcohol: recommendations for future studies.
- Bobinac A, van Exel NJA, Rutten FF, et al. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation. J Health Econ. 2012;31(1):158–168.
- Mosquera J, and Rodríguez-Míguez E. Intangible costs of alcohol dependence from the perspective of patients and their relatives: a contingent valuation study. Adicciones. 2018;30(2):111–121.
- Blomquist GC, Blumenschein K, Johannesson M. Eliciting willingness to pay without bias using follow-up certainty statements: comparisons between probably/definitely and a 10-point certainty scale. Environmental and Resource Economics. 2009;43(4):473–502.
- Rosko MD, DeVita M, McKenna WF, et al. Strategic marketing applications of conjoint analysis: an HMO perspective. Journal of Health Care Marketing. 1985. 5(4).
- Gonzalez JM. A guide to measuring and interpreting attribute importance. Patient-Patient-Centered Outcomes Res. 2019;12(3):287–295.
- Polsky D, Glick HA, Willke R, et al. Confidence intervals for cost–effectiveness ratios: a comparison of four methods. Health Econ. 1997;6(3):243–252.
- O’Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference? Med Decis Mak. 1994;14(3):289–297.
- Pinto-Prades JL, Loomes G, Brey R. Trying to estimate a monetary value for the QALY. J Health Econ. 2009;28(3):553–562.
- Smith RD. The relative sensitivity of willingness‐to‐pay and time‐trade‐off to changes in health status: an empirical investigation. Health Econ. 2001;10(6):487–497.
- Bala MV, Wood LL, Zarkin GA, et al. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol. 1998;51(8):667–676.
- Robinson A, Gyrd-Hansen D, Bacon P, et al. Estimating a WTP-based value of a QALY: the ‘chained’approach. Soc Sci Med. 2013;92:92–104.
- Martín-Fernández J, Polentinos-Castro E, Del Cura-gonzález MI, et al. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences. BMC Health Serv Res. 2014;14(1):287.
- Van Houtven G, Powers J, Jessup A, et al. Valuing avoided morbidity using meta‐regression analysis: what can health status measures and QALYs tell us about WTP? Health Econ. 2006;15(8):775–795.
- Hammitt JK, Haninger K. Willingness to pay for food safety: sensitivity to duration and severity of illness. Am J Agric Econ. 2007;89(5):1170–1175.
- Haninger K, Hammitt JK. Diminishing willingness to pay per Quality‐Adjusted life year: valuing acute foodborne illness. Risk Analysis: An International Journal. 2011;31(9):1363–1380.
- Rodríguez-Míguez E, Pinto-Prades JL, Mosquera-Nogueira J. Eliciting health state utilities using paired-gamble methods: the role of the starting point. Value Health. 2019;22(4):446–452.
- Soeteman L, van Exel J, Bobinac A. The impact of the design of payment scales on the willingness to pay for health gains. Eur J Health Econ. 2017;18(6):743–760.
- Goldberg I, Roosen J. Scope insensitivity in health risk reduction studies: a comparison of choice experiments and the contingent valuation method for valuing safer food. Journal of Risk and Uncertainty. 2007;34(2):123–144.
- Kanya L, Sanghera S, Lewin A, et al. The criterion validity of willingness to pay methods: a systematic review and meta-analysis of the evidence. Soc Sci Med. 2019;232:238–261.
- Blumenschein K, Blomquist GC, Johannesson M, et al. Eliciting willingness to pay without bias: evidence from a field experiment. Econ J. 2008;118(525):114–137.
- Picci RL, Oliva F, Zuffranieri M, et al. Quality of life, alcohol detoxification and relapse: is quality of life a predictor of relapse or only a secondary outcome measure? Qual Life Res. 2014;23(10):2757–2767.
- Gyrd-Hansen D. Willingness to pay for a QALY. Pharmacoeconomics. 2005;23(5):423–432.
- Nice. Appraising life-extending, end of life treatments. London(UK): National Institute for Health and Clinical Excellence; 2009.
- Gu Y, Lancsar E, Ghijben P, et al. Attributes and weights in health care priority setting: a systematic review of what counts and to what extent. Soc Sci Med. 2015;146:41–52.
- Nord E, Johansen R. Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy. 2014;116(2–3):281–288.
- Lancsar E, Gu Y, Gyrd-Hansen D, et al. The relative value of different QALY types. J Health Econ. 2020;70:102303.